Suja Life, Inc. (NASDAQ: SUJA) is a Consumer Defensive company (Beverages - Non-Alcoholic) with a market capitalization of $156M. The Maz Rating grades it against the other companies in its sector.
Suja Life, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.54, Suja Life, Inc. trades at 0.4x sales and 1.4x book value. Over the last twelve months it generated about $354M of revenue and a net loss of $820321. It runs a gross margin of 48.1%, an operating margin of -0.7% and a net margin of -0.3%. It shows return on equity of -1.1%, return on invested capital of -0.7% and a free cash flow yield of -15.1%. On the balance sheet: a debt-to-equity ratio of 1.67 and a current ratio of 1.27. Over the past 52 weeks the share price ranged from $5.59 to $18.48, with a beta of 0.23.
Suja Life, Inc. does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 2 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Suja Life, Inc. stands out as a leading innovator in the health-conscious beverage market, spearheading the revolution of functional and beneficial drinks. The company's core mission is to redefine the beverage landscape by delivering delightful and nourishing products that promote healthier daily habits for consumers across the nation. Suja Life manages a respected portfolio of brands, including Suja Organic, Vive Organic, and Slice, which provide organic cold-pressed juices and potent wellness shots widely enjoyed throughout the country. Operating as a fully integrated manufacturer, the firm is dedicated to utilizing organic, non-GMO, and plant-derived ingredients to create beverages that offer exceptional flavor and genuine health advantages, without any compromise. Established in 2012, its corporate headquarters are located in Oceanside, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Suja Life, Inc. (SUJA) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 72.6% / 30% · (Cash+Inv) / Mkt Cap (36m) 6.90% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 72.6% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 6.90% / 33% · Receivables / Mkt Cap (36m) 6.80% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 72.6% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 6.90% / 33.33% · Receivables / Mkt Cap (24m) 6.80% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 47.3% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 5.68% / 33.33% · Receivables / Avg Assets (4Q) 3.44% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 39.7% / 33.33% · (Cash+ST Inv) / Total Assets 3.77% / 33.33% · (Cash+Recv) / Total Assets 7.49% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Suja Life, Inc. (SUJA) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Suja Life, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
Suja Life, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 28, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.